Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
January 08 2025 - 2:04PM
Edgar (US Regulatory)
EXHIBIT 99.1
JOINT FILING AGREEMENT
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Palvella Therapeutics, Inc.
Date: January 8, 2025
FRAZIER LIFE SCIENCES PUBLIC FUND, L.P.
By: FHMLSP, L.P., its General Partner
By: FHMLSP, L.L.C., its General Partner
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
FHMLSP, L.P.
By: FHMLSP, L.L.C., its General Partner
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
FHMLSP, L.L.C.
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
FRAZIER LIFE SCIENCES PUBLIC OVERAGE FUND, L.P.
By: FHMLSP Overage, L.P., its General Partner
By: FHMLSP Overage, L.L.C., its General Partner
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
FHMLSP OVERAGE, L.P.
By FHMLSP Overage, L.L.C., its General Partner
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
FHMLSP OVERAGE, L.L.C.
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
FRAZIER LIFE SCIENCES XI, L.P.
By: FHMLS XI, L.P., its General Partner
By: FHMLS XI, L.L.C., its General Partner
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
FHMLS XI, L.P.
By: FHMLS XI, L.L.C., its General Partner
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
FHMLS XI, L.L.C.
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
FRAZIER LIFE SCIENCES X, L.P.
By: FHMLS X, L.P., its General Partner
By: FHMLS X, L.L.C., its General Partner
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
FHMLS X, L.P.
By: FHMLS X, L.L.C., its General Partner
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
FHMLS X, L.L.C.
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
By: *
James N. Topper
Date: January 8, 2025
By: *
Patrick J. Heron
Date: January 8, 2025
By: **
Albert Cha
Date: January 8, 2025
By: **
James Brush
Date: January 8, 2025
By: ***
Daniel Estes
Date: January 8, 2025
By: /s/ Steve R. Bailey
Steve R. Bailey, as Attorney-in-Fact
*This Joint Filing Agreement was executed by Steve R. Bailey on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on March 29, 2016.
**This Joint Filing Agreement was executed by Steve R. Bailey on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021.
***This Joint Filing Agreement was executed by Steve R. Bailey on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on April 18, 2022.
Palvella Therapeutics (NASDAQ:PVLA)
Historical Stock Chart
From Dec 2024 to Jan 2025
Palvella Therapeutics (NASDAQ:PVLA)
Historical Stock Chart
From Jan 2024 to Jan 2025
